Genistein and daidzein, in combination, protect cellular integrity during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 8, Issue 2, 2011, Pages 91-97

  Pugalendhi, Pachaiappan ^a   Manoharan, Shanmugam ^a   Suresh, Kathiresan ^a   Baskaran, Nagarethinam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Daidzein; DMBA; Genistein; Glycoconjugates; Mammary carcinoma; Membrane integrity

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DAIDZEIN; FUCOSE; GENISTEIN; GLYCOCONJUGATE; HEXOSAMINE; HEXOSE; ISOFLAVONE DERIVATIVE; SIALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BREAST; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; FEMALE; HISTOPATHOLOGY; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PLASMA; PROTEIN EXPRESSION; RAT;

EID: 79960323900     PISSN: 01896016     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v8i2.63196     Document Type: Article

References (37)

1. Apweiler, R., Hermjakob, H. and Sharon, N. (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochem Biophys Acta. 1473:4-8.
2. Bossmann, H.B. and Hall, T.C. (1974). Enzyme activity in invasive tumours of human breast and colon. Proc. Natl. Acad. Sci., USA. 71:1833-1837.
3. Celil, U., Seyithan, T., Fatih, A., Yavuz, S. and Nuri, B. (2003). Serum free and bound sialic acid and Alpha-1-acid glycoprotein in patients with laryngeal cancer. Annals of Clinical & Laboratory Science. 33:156-159.
4. Dische, L. and Shettles, L.B. (1948). Specific color reactions of methyl pentoses and spectrophotometric micromethod for their determination. J Biol Chem. 175:595-604.
5. Dodge J.F., Michell, G. and Hanahan, D.J. (1968). The preparation of hemoglobin free ghosts of human red blood cells. Arch Biochem Biophys. 110:119-130.
6. Dube, D.H. and Bertozzi, C.R. (2005). Glycans in cancer and inflammation-Potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4:477-488.
7. Elangovan, V., Nalini, R., Balasubramanian, S., Sekar, N. and Govindasamy, S. (1994). Studies on the antiproliferative effective of some naturally occurring bioflavonoidal compounds against human carcinoma of larynx and sarcoma-180 cell lines. Indian J. Pharmacol. 26:266-269.
8. Guo, Q., Rimbach, G., Moini, H., Weber, S. and Packer, L. (2002). ESR and cell line culture studies on free radicalscavenging and antioxidant activities of isoflavonoids. Toxicology. 179:171-180.
9. Hakomori, S, (2002). Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl. Acad. Sci. U S A. 99:10231-3.
10. Hortobagyi, G.N., Jde, S.L. and Pritchard, K. (2005). The global breast cancer burden: Variations in epidemiology and survival. Clin. Breast Cancer. 6:391-401.
11. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. (2009). Cancer statistics, 2009. CA Cancer J Clin. 59:225-249.
12. Katopodis, N.N. and Stock, C.C. (1980). Improved method to determine lipid bound sialic acid in plasma. Res. Commun. Chem. Pathol. Pharmacol. 30:171-180.
13. Kobata, A. and Amano, J. (2005). Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol. 83:429-439.
14. Kolanjiappan, K. and Manoharan, S. (2005). Chemopreventive efficacy and anti-lipid peroxidative potential of Jasminum grandiflorum Linn. on 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis. Fund. Clin. Pharm. 19:687-693.
15. Listinsky, J.J., Listinsky, C.M. and Alapati, V. (2001). Cell surface fucose ablation as a therapeutic strategy for malignant neoplasms. Adv. Anat. Pathol. 8:330-7.
16. Manoharan, S., Padmanabhan, M., Kolanjiappan, K., Ramachandran, C.R. and Suresh, K. (2004). Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clin. Chim. Acta. 339:91-96.
17. Manoharan, S., Panjamurthy, K., Pugalendhi, P., Balakrishnan, S., Rajalingam, K., Vellaichamy, L. and Maryalias, L. (2009). Protective role of withaferin-A on red blood cell integrity during 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis. Afr. J. Trad. CAM. 6:94-102.
18. McDonagh, J.C. and Nathan, R.D. (1990). Sialic acid and the surface charge of delayed rectifier potassium channels. J Mol. Cell Cardiol. 22:1305-1316.
19. Mishra, P., Kar, A. and Kale, R.K. (2009). Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: The role of peroxidative damage and antioxidative enzymes. Mol. Cell Biochem. 325:149-57.
20. Nachbar, M.S. and Oppenheim, J.D., and Aull, F. (1974). Cell surface contributions to the malignant process. Am. J. Med. Sci. 268:122-138.
21. Narayana, S. (1994). Sialic acid as a tumor marker. Ann Clin Lab Sci. 24:376-84.
22. Niebes, P. (1972). Determination of enzymes and degradation product of glycosaminoglycan metabolism in the serum of health and various subjects. Clin Chim Acta. 42:399-408.
23. Patel, P.S., Adhvaryu, S.G., Balar, D.B., Parikh, B.J. and Shah, P.M. (1994). Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res. 14:747-752.
24. Patel, P.S., Baxi, B.R. and Balar, P.B. (1989). Significance of serum sialoglycoproteins in patients with lung cancer. Neoplasma. 36:53-9.
25. Pugalendhi, P. and Manoharan, S. (2010). Chemopreventive potential of genistein and daidzein in combination during 7,12-dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats. Pak J Biol Sci. 13:279-286.
26. Quist, E.E. (1980). Regulation of erythrocyte membrane shape by Ca2+. Biochem Biophys Res Commun. 92:631-637.
27. Ramprasath, V.R., Akila, G., Shanthi, P. and Sachdanandam, P. (2007). Biochemical evaluation of glycoprotein components, Lysosomal enzymes and marker enzymes upon kalpaamruthaa administration in experimental mammary carcinoma rats. Journal of Health Sciences. 53:644-654.
28. Rao, V.R., Krishnamoorthy, L., Kumaraswamy, S.V. and Ramaswamy, G. (1998). Circulating levels in serum of total sialic acid, lipid-associated sialic acid and fucose in precancerous lesions and cancer of the oral cavity. Cancer Detect Prev. 22:237-240.
29. Ruffer, C.E. and Kulling, S.E. (2006). Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem 54:2926-2931
30. Ruiz-Larrea, M.B., Mohan, A.R., Paganga, G., Miller, N.J., Bolwell, G.P. and Rice-Evans, C.A. (1997). Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res, 26:63-70.
31. Sarkar, F.H. and Li, Y. (2002). Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews. 21:265-280.
32. Senthil, N., Manoharan, S., Balakrishnan, S., Ramachandran, C.R., Muralinaidu, R. and Rajalingam, K. (2007). Modifying effects of Piper longum on cell surface abnormalities in 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis. Int. J. Pharmacol. 3:290-294.
33. Suresh, K., Manoharan, S., Panjamurthy, K. and Senthil, N. (2007). Modifying effects of Annona squamosa on glycoconjugates levels in 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. J. Med. Sci. 7:100-105.
34. Verma, S.P. and Goldin, B.R. (1998). Effect of soy-derived isoflavonoids on the induced growth of MCF-7cells by estrogenic environmental chemicals. Ntr. Cancer. 30:232-239.
35. Wagner, W.D. (1979). A more sensitive assay discriminating galactosamine and glucosamine in mixture. Anal. Biochem. 94:369-394.
36. Warren, L. (1959). Thiobarbituric acid and assay of sialic acid. J. Biol. Chem. 30:171-180.
37. Yang, Z. and Hancock, W.S. (2004). Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J Chromatogr A 1053:79-88.